HUP0102527A3 - Aryl phosphate derivatives of d4t having anti-hiv activity, medicaments containing the same and their use - Google Patents

Aryl phosphate derivatives of d4t having anti-hiv activity, medicaments containing the same and their use

Info

Publication number
HUP0102527A3
HUP0102527A3 HU0102527A HUP0102527A HUP0102527A3 HU P0102527 A3 HUP0102527 A3 HU P0102527A3 HU 0102527 A HU0102527 A HU 0102527A HU P0102527 A HUP0102527 A HU P0102527A HU P0102527 A3 HUP0102527 A3 HU P0102527A3
Authority
HU
Hungary
Prior art keywords
same
hiv activity
aryl phosphate
medicaments containing
phosphate derivatives
Prior art date
Application number
HU0102527A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Parker Hughes Inst St Paul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst St Paul filed Critical Parker Hughes Inst St Paul
Publication of HUP0102527A2 publication Critical patent/HUP0102527A2/hu
Publication of HUP0102527A3 publication Critical patent/HUP0102527A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HU0102527A 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity, medicaments containing the same and their use HUP0102527A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/107,716 US6030957A (en) 1998-06-29 1998-06-29 Aryl phosphate derivatives of d4T having anti-HIV activity
PCT/US1999/014774 WO2000000501A1 (en) 1998-06-29 1999-06-29 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY

Publications (2)

Publication Number Publication Date
HUP0102527A2 HUP0102527A2 (hu) 2001-12-28
HUP0102527A3 true HUP0102527A3 (en) 2002-04-29

Family

ID=22318071

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102527A HUP0102527A3 (en) 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity, medicaments containing the same and their use

Country Status (14)

Country Link
US (7) US6030957A (https=)
EP (1) EP1090018B1 (https=)
JP (1) JP2002519355A (https=)
KR (1) KR20010071673A (https=)
CN (1) CN1314909A (https=)
AT (1) ATE277940T1 (https=)
AU (1) AU4846999A (https=)
BR (1) BR9911685A (https=)
CA (1) CA2336285A1 (https=)
DE (1) DE69920696T2 (https=)
HU (1) HUP0102527A3 (https=)
IL (1) IL140388A0 (https=)
NO (1) NO20006685L (https=)
WO (1) WO2000000501A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144874B2 (en) * 2002-10-25 2006-12-05 Parker Hughes Institute Aryl phosphate derivatives of d4T having activity against resistant HIV strains
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity
US20070015733A1 (en) * 1998-06-29 2007-01-18 Parker Hughes Institute Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains
AU3897800A (en) * 1999-03-19 2000-10-09 Parker Hughes Institute One pot synthesis of 5'-hydroxy phosphorylated nucleoside derivatives, and compounds formed thereby
US6825177B2 (en) * 2000-10-30 2004-11-30 Parker Hughes Institute Aryl phosphate derivatives of d4T with potent anti-viral activity
DK1334108T3 (da) * 2000-11-13 2005-07-11 Parker Hughes Inst Arylfosfatderivater af d4T
US7405202B2 (en) * 2002-05-28 2008-07-29 Regents Of The University Of Minnesota CRISP polypeptides as contraceptives and inhibitors of sperm capacitation
US20030236218A1 (en) * 2002-06-12 2003-12-25 Uckun Fatih M. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
US20040076931A1 (en) * 2002-10-18 2004-04-22 Cashflow Technologies, Inc. Educational interactive games
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
GB0401088D0 (en) 2004-01-19 2004-02-18 Univ Cardiff Phosphoramidate derivatives
CA2571079A1 (en) * 2004-06-24 2006-02-02 Merck & Co., Inc. Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
WO2006026656A1 (en) * 2004-08-31 2006-03-09 Parker Hughes Institute Cytotoxic nucleoside analog compound 003 for treating cancer
WO2006063149A1 (en) 2004-12-09 2006-06-15 Regents Of The University Of Minnesota Nucleosides with antiviral and anticancer activity
JP2008535648A (ja) * 2005-03-09 2008-09-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ナノ複合膜ならびにそれを作製および使用する方法
US7892618B2 (en) * 2005-03-21 2011-02-22 Sony Corporation Deterring theft of optical media
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
JP2012521359A (ja) * 2009-03-20 2012-09-13 アリオス バイオファーマ インク． 置換されたヌクレオシドアナログおよびヌクレオチドアナログ
NZ607996A (en) 2010-09-22 2014-07-25 Alios Biopharma Inc Substituted nucleotide analogs
US9095599B2 (en) 2011-01-03 2015-08-04 Nanjing Molecular Research, Inc. O-(substituted benzyl) phosphoramidate compounds and therapeutic use
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
HK1206362A1 (zh) 2012-03-21 2016-01-08 Alios Biopharma, Inc. 硫代氨基磷酸酯核苷酸前藥的固體形式
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
US9447132B2 (en) 2013-04-12 2016-09-20 Achillion Pharmaceuticals, Inc. Highly active nucleoside derivative for the treatment of HCV

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707362A (en) 1985-02-15 1987-11-17 Biotek, Inc. Sustained release composition
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
JPH06189998A (ja) 1992-11-06 1994-07-12 C & Co:Yugen コンド―ム
EP0626970A1 (en) 1992-12-18 1994-12-07 The University Of Alberta Dihydropyrimidine nucleosides with antiviral properties
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine
US5659023A (en) * 1995-02-01 1997-08-19 Gilead Sciences, Inc. Nucleotide analogues
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
BR9709228A (pt) 1996-05-09 1999-08-10 Michel G Bergeron Método e formulações para prevenir e/ou tratar qualquer infecção (especificamente as dst incluindo hiv) inflamátoria neoplastica ou qualquer outro tipo de doenças das mucosas e/ou pele
US6030957A (en) 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity

Also Published As

Publication number Publication date
HUP0102527A2 (hu) 2001-12-28
KR20010071673A (ko) 2001-07-31
DE69920696T2 (de) 2006-03-02
JP2002519355A (ja) 2002-07-02
BR9911685A (pt) 2001-12-18
AU4846999A (en) 2000-01-17
US6537975B1 (en) 2003-03-25
DE69920696D1 (de) 2004-11-04
US6503890B1 (en) 2003-01-07
EP1090018B1 (en) 2004-09-29
EP1090018A1 (en) 2001-04-11
NO20006685D0 (no) 2000-12-28
IL140388A0 (en) 2002-02-10
US6528495B1 (en) 2003-03-04
WO2000000501A1 (en) 2000-01-06
US7071176B2 (en) 2006-07-04
ATE277940T1 (de) 2004-10-15
CN1314909A (zh) 2001-09-26
NO20006685L (no) 2001-02-28
US6670336B1 (en) 2003-12-30
US6350736B1 (en) 2002-02-26
US20040171577A1 (en) 2004-09-02
US6030957A (en) 2000-02-29
CA2336285A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
HUP0102527A3 (en) Aryl phosphate derivatives of d4t having anti-hiv activity, medicaments containing the same and their use
HUP0104497A3 (en) Benzamide derivatives, their preparation, medicaments containing them and their use
EE04354B1 (et) Indolüül-3-glüoksüülhappe derivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldavad kasvajavastase toimega ravimid
HUP0004225A3 (en) Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
AU2498597A (en) New benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
HUS1200028I1 (hu) 4"-Szubsztituált-9-dezoxo-9a-aza-9a-homoeritromicin-származékok és ezeket tartalmazó gyógyszerek
HUP9801948A3 (en) Oxygenated-heterocycle containing sulfonamides and medicaments containing the same compounds
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
HUP0101461A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
IL135986A0 (en) Chrysamine g derivatives and pharmaceutical and diagnostic compositions containing the same
HUP0100059A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
PL329177A1 (en) Derivatives of azahexane ehxibiting antiviral activity
IL127056A (en) Aryl pyrimidine derivatives, their preparation and pharmaceutical compositions comprising them
HUP0102585A3 (en) Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
GB2327675B (en) Nicotinamide derivatives and their use as medicaments
LT2000004A (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
HUP0002718A3 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
EP0303186A3 (en) Aryl phosphorus derivatives, their preparation and their use
HUP0000941A3 (en) Sulfamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
IL83509A0 (en) Pyrimidine derivatives,their manufacture and medicaments containing them
AU6935498A (en) Novel phosphate compounds and their use as medicaments
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
HU9701080D0 (en) Pharmaceutical composition of antiviral activity
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
IL136612A0 (en) Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same